Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABLX

Ablynx (ABLX) Stock Price, News & Analysis

Ablynx logo

About Ablynx Stock (NASDAQ:ABLX)

Advanced Chart

Key Stats

Today's Range
$52.87
$52.87
50-Day Range
N/A
52-Week Range
$17.75
$55.29
Volume
N/A
Average Volume
249,005 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ablynx and its competitors with MarketBeat's FREE daily newsletter.

ABLX Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
ABLX News
Ablynx NV ADR (ABLX)
Ablynx NV (EBR:ABLX): What Does The Future Look Like?
See More Headlines

ABLX Stock Analysis - Frequently Asked Questions

Ablynx (ABLX) raised $151 million in an initial public offering on Wednesday, October 25th 2017. The company issued 7,200,000 shares at a price of $20.95 per share. BofA Merrill Lynch, J.P. Morgan and Jefferies served as the underwriters for the IPO and Baird, Bryan, Garnier and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ablynx investors own include Galapagos (GLPG), argenex (ARGX), Ablynx (ABLYF), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY) and Aurora Cannabis (ACBFF).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ABLX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ABLX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners